These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36387759)

  • 1. Incidence and profile of severe exacerbations of chronic obstructive pulmonary disease due to biomass smoke or tobacco.
    Golpe R; Blanco-Cid N; Dacal-Rivas D; Martín-Robles I; Veiga I; Guzmán-Peralta I; Castro-Añón O; Pérez-de-Llano LA
    Ann Thorac Med; 2022; 17(4):193-198. PubMed ID: 36387759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stability of blood eosinophils in acute exacerbation of chronic obstructive pulmonary disease and its relationship to clinical outcomes: a prospective cohort study.
    Cui Y; Zhang W; Ma Y; Zhan Z; Chen Y
    Respir Res; 2021 Nov; 22(1):301. PubMed ID: 34819051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD Exacerbation: Why It Is Important to Avoid ICU Admission.
    Prediletto I; Giancotti G; Nava S
    J Clin Med; 2023 May; 12(10):. PubMed ID: 37240474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of CRP, Procalcitonin, Neutrophil Counts, Eosinophil Counts, sTREM-1, and OPN between Pneumonic and Nonpneumonic Exacerbations in COPD Patients.
    Mou S; Zhang W; Deng Y; Tang Z; Jiang D
    Can Respir J; 2022; 2022():7609083. PubMed ID: 35400078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can red blood cell distribution width (RDW) level predict the severity of acute exacerbation of chronic obstructive pulmonary disease (AECOPD)?
    Alparslan Bekir S; Tuncay E; Gungor S; Yalcinsoy M; Sogukpinar Ö; Gundogus B; Aksoy E; Agca M; Agca Altunbey S; Turker H; Karakurt Z
    Int J Clin Pract; 2021 Nov; 75(11):e14730. PubMed ID: 34383359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient characteristics associated with risk of first hospital admission and readmission for acute exacerbation of chronic obstructive pulmonary disease (COPD) following primary care COPD diagnosis: a cohort study using linked electronic patient records.
    Hunter LC; Lee RJ; Butcher I; Weir CJ; Fischbacher CM; McAllister D; Wild SH; Hewitt N; Hardie RM
    BMJ Open; 2016 Jan; 6(1):e009121. PubMed ID: 26801463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-to-Lymphocyte Ratio Predicts Clinical Outcome of Severe Acute Exacerbation of COPD in Frequent Exacerbators.
    Lu FY; Chen R; Li N; Sun XW; Zhou M; Li QY; Guo Y
    Int J Chron Obstruct Pulmon Dis; 2021; 16():341-349. PubMed ID: 33633446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories of Severe Exacerbations of Chronic Obstructive Pulmonary Disease and Their Relationship with Mortality Risk.
    Golpe R; Figueira-Gonçalves JM; Amado-Diago CA; Expósito-Marrero A; González-Ramos L; Dacal-Rivas D; García-Talavera I; Esteban C
    Lung; 2022 Oct; 200(5):601-607. PubMed ID: 36065068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Role of White Blood Cell Differential Count for the Development of Acute Exacerbation in Korean Chronic Obstructive Pulmonary Disease.
    Yoon EC; Koo SM; Park HY; Kim HC; Kim WJ; Kim KU; Jung KS; Yoo KH; Yoon HK; Yoon HY
    Int J Chron Obstruct Pulmon Dis; 2024; 19():17-31. PubMed ID: 38192972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Acute Exacerbation and Its Phenotypes on the Clinical Outcomes of Chronic Obstructive Pulmonary Disease in Hospitalized Patients: A Cross-Sectional Study.
    Kaleem Ullah M; Parthasarathi A; Biligere Siddaiah J; Vishwanath P; Upadhyay S; Ganguly K; Anand Mahesh P
    Toxics; 2022 Nov; 10(11):. PubMed ID: 36355958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comprehension and recognition of acute exacerbation among chronic obstructive pulmonary disease patients].
    Jiang M; Ma JF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1030-4. PubMed ID: 24378002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 30-day Readmission After an Acute Exacerbation of Chronic Obstructive Pulmonary Disease is Associated with Cardiovascular Comorbidity.
    Ozgen Alpaydin A; Ozuygur SS; Sahan C; Tertemiz KC; Russell R
    Turk Thorac J; 2021 Sep; 22(5):369-375. PubMed ID: 35110209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in care between general medicine and respiratory specialists in the management of patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease.
    Wijayaratne K; Wilson J; Sivakumaran P; Sriram KB
    Ann Thorac Med; 2013 Oct; 8(4):197-203. PubMed ID: 24250732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of sequential treatment with syndrome differentiation on acute exacerbation of chronic obstructive pulmonary disease and "AECOPD Risk-Window": study protocol for a randomized placebo-controlled trial.
    Haifeng W; Jiansheng L; Suyun L; Xueqing Y; Hailong Z; Zhiwan W; Qiyi W; Pankui Z; Zhongchao W; Fenglei L; Haihong Y
    Trials; 2012 Apr; 13():40. PubMed ID: 22520863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Systemic Corticosteroids in Patients With an Acute Exacerbation of COPD and a Diagnosis of Pneumonia.
    Scholl T; Kiser TH; Vondracek SF
    Chronic Obstr Pulm Dis; 2018 Jan; 5(1):57-65. PubMed ID: 29629405
    [No Abstract]   [Full Text] [Related]  

  • 16. The Association of Depressive Symptoms With Rates of Acute Exacerbations in Patients With COPD: Results From a 3-year Longitudinal Follow-up of the ECLIPSE Cohort.
    Yohannes AM; Mülerová H; Lavoie K; Vestbo J; Rennard SI; Wouters E; Hanania NA
    J Am Med Dir Assoc; 2017 Nov; 18(11):955-959.e6. PubMed ID: 28733182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial.
    Bates J; Francis NA; White P; Gillespie D; Thomas-Jones E; Breen R; Kirby N; Hood K; Gal M; Phillips R; Naik G; Cals J; Llor C; Melbye H; Wootton M; Riga E; Cochrane A; Howe R; Fitzsimmons D; Sewell B; Alam MF; Butler CC
    Trials; 2017 Sep; 18(1):442. PubMed ID: 28969667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of acute exacerbations in chronic obstructive pulmonary disease associated with biomass smoke compared with tobacco smoke.
    Cho J; Lee CH; Hwang SS; Kim KU; Lee SH; Park HY; Park SJ; Min KH; Oh YM; Yoo KH; Jung KS;
    BMC Pulm Med; 2019 Mar; 19(1):68. PubMed ID: 30902075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of 12-Month Readmission for Hospitalized Patients with COPD: A Propensity Score Matched Analysis of Prospective Multicenter Study.
    Xu T; Sun W; Zhao H; Wang X; Yuan Q; Zhang X; Mao S; Zhang X; Zhao M; Sheng Z; Zhang M; Huang M; Ji N
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2329-2341. PubMed ID: 36164549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Blood Markers at Admission for Predicting Community Acquired Pneumonia in Chronic Obstructive Pulmonary Disease.
    Gao S; Duan Y; Chen J; Wang J
    COPD; 2021 Oct; 18(5):557-566. PubMed ID: 34511022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.